Epidemiology of mucopolysaccharidoses.
Khan SA, Peracha H, Ballhausen D, Wiesbauer A, Rohrbach M, Gautschi M, Mason RW, Giugliani R, Suzuki Y, Orii KE, Orii T, Tomatsu S.
Mol Genet Metab. 2017 Jul;121(3):227-240. doi: 10.1016/j.ymgme.2017.05.016. Epub 2017 May 26.
Hurler's, Hunter's and Morquio's syndromes. A biochemical study in the light of current views of the underlying defects.
Dean MF, Muir H, Ewins RJ.
Biochem J. 1971 Aug;123(5):883-94. doi: 10.1042/bj1230883.
Fusions at the craniovertebral junction.
Ahmed R, Traynelis VC, Menezes AH.
Childs Nerv Syst. 2008 Oct;24(10):1209-24. doi: 10.1007/s00381-008-0607-7. Epub 2008 Apr 4.
Activity of daily living for Morquio A syndrome.
Yasuda E, Suzuki Y, Shimada T, Sawamoto K, Mackenzie WG, Theroux MC, Pizarro C, Xie L, Miller F, Rahman T, Kecskemethy HH, Nagao K, Morlet T, Shaffer TH, Chinen Y, Yabe H, Tanaka A, Shintaku H, Orii KE, Orii KO, Mason RW, Montaño AM, Fukao T, Orii T, Tomatsu S.
Mol Genet Metab. 2016 Jun;118(2):111-22. doi: 10.1016/j.ymgme.2016.04.005. Epub 2016 Apr 25.
Cervicothoracic myelopathy in children with Morquio syndrome A: a report of 4 cases.
Baratela WA, Bober MB, Thacker MM, Belthur MV, Oto M, Rogers KJ, Mackenzie WG.
J Pediatr Orthop. 2014 Mar;34(2):223-8. doi: 10.1097/BPO.0000000000000074.
Mucopolysaccharidosis type IV: report of 5 cases of Morquio Syndrome.
Cadena Arteaga JA, Lasso Andrade FA, Achicanoy Puchana DM, Achicanoy Puchana DF, Caicedo Morillo GN, Medina Bravo PA, Juez Neira WF, Vanegas Bastidas CR, Montoya Ríos DC, Vasquez Correa KJ, Suárez Cuéllar LC, Osorio Segura LJ.
Radiol Case Rep. 2021 Dec 3;17(2):385-391. doi: 10.1016/j.radcr.2021.11.012. eCollection 2022 Feb.
Clinical outcomes in a subpopulation of adults with Morquio A syndrome: results from a long-term extension study of elosulfase alfa.
Hughes D, Giugliani R, Guffon N, Jones SA, Mengel KE, Parini R, Matousek R, Hawley SM, Quartel A.
Orphanet J Rare Dis. 2017 May 23;12(1):98. doi: 10.1186/s13023-017-0634-0.
Multi-domain impact of elosufase alfa in Morquio A syndrome in the pivotal phase III trial.
Hendriksz CJ, Giugliani R, Harmatz P, Mengel E, Guffon N, Valayannopoulos V, Parini R, Hughes D, Pastores GM, Lau HA, Al-Sayed MD, Raiman J; STRIVE Investigators; Yang K, Mealiffe M, Haller C.
Mol Genet Metab. 2015 Feb;114(2):178-85. doi: 10.1016/j.ymgme.2014.08.012. Epub 2014 Sep 6.
Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.
Tomatsu S, Sawamoto K, Alméciga-Díaz CJ, Shimada T, Bober MB, Chinen Y, Yabe H, Montaño AM, Giugliani R, Kubaski F, Yasuda E, Rodríguez-López A, Espejo-Mojica AJ, Sánchez OF, Mason RW, Barrera LA, Mackenzie WG, Orii T.
Drug Des Devel Ther. 2015 Apr 1;9:1937-53. doi: 10.2147/DDDT.S68562. eCollection 2015.
Understanding bias when estimating life expectancy from age at death: a simulation approach applied to Morquio syndrome A.
Yin X, Ahn J, Boca SM.
BMC Res Notes. 2022 Jan 15;15(1):19. doi: 10.1186/s13104-021-05894-0.
